Camille L. Bedrosian

Insider Reports History

Location
Novato, CA
Signature
/s/ Joshua B. Cohen, as Attorney in Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Camille L. Bedrosian:

Company Role Class Num Shares Value Price $ Report Date Ownership
Amylyx Pharmaceuticals, Inc. Chief Medical Officer Common Stock 265,285 $3,790,922 $14.29 05 Mar 2026 Direct
Ultragenyx Pharmaceutical Inc. EVP and Chief Medical Officer Common Stock 46,720 $981,120 $21.00 01 Mar 2023 Direct
Crinetics Pharmaceuticals, Inc. Director Common Stock 16,300 $543,116 $33.32 11 Jun 2025 Direct
RHYTHM PHARMACEUTICALS, INC. Director Common Stock 7,000 $421,260 $60.18 18 Jun 2025 Direct
RHYTHM PHARMACEUTICALS, INC. Director Restricted Stock Units 4,712 $0 $39.10 24 Jun 2025 Direct
Amylyx Pharmaceuticals, Inc. Chief Medical Officer Stock Option (Right to Buy) 143,985 05 Mar 2026 Direct
Crinetics Pharmaceuticals, Inc. Director Stock Option (right to buy) 10,350 11 Jun 2025 Direct
RHYTHM PHARMACEUTICALS, INC. Director Stock Option (right to buy) 7,037 24 Jun 2025 Direct

Insider Reports Filed by Camille L. Bedrosian

Symbol Company Period Transactions Value $ Form Type Role Filing Time
AMLX Amylyx Pharmaceuticals, Inc. 05 Mar 2026 2 $0 4 Chief Medical Officer 09 Mar 2026, 16:00
AMLX Amylyx Pharmaceuticals, Inc. 02 Mar 2026 1 -$94,205 4 Chief Medical Officer 04 Mar 2026, 16:00
AMLX Amylyx Pharmaceuticals, Inc. 01 Dec 2025 1 -$94,418 4 Chief Medical Officer 03 Dec 2025, 16:39
AMLX Amylyx Pharmaceuticals, Inc. 30 Sep 2025 1 -$175,518 4 Chief Medical Officer 02 Oct 2025, 16:15
RYTM RHYTHM PHARMACEUTICALS, INC. 24 Jun 2025 2 $0 4 Director 26 Jun 2025, 16:56
RYTM RHYTHM PHARMACEUTICALS, INC. 18 Jun 2025 2 $0 4 Director 23 Jun 2025, 16:52
CRNX Crinetics Pharmaceuticals, Inc. 11 Jun 2025 2 $0 4 Director 13 Jun 2025, 16:30
AMLX Amylyx Pharmaceuticals, Inc. 31 Mar 2025 1 -$43,082 4 Chief Medical Officer 02 Apr 2025, 17:14
AMLX Amylyx Pharmaceuticals, Inc. 06 Mar 2025 2 $0 4 Chief Medical Officer 10 Mar 2025, 20:32
AMLX Amylyx Pharmaceuticals, Inc. 02 Dec 2024 1 -$30,007 4 Chief Medical Officer 03 Dec 2024, 17:21
AMLX Amylyx Pharmaceuticals, Inc. 30 Sep 2024 1 -$36,559 4 Chief Medical Officer 02 Oct 2024, 18:50
RYTM RHYTHM PHARMACEUTICALS, INC. 21 Jun 2024 2 $0 4 Director 25 Jun 2024, 16:37
RYTM RHYTHM PHARMACEUTICALS, INC. 18 Jun 2024 2 $0 4 Director 20 Jun 2024, 21:41
CRNX Crinetics Pharmaceuticals, Inc. 07 Jun 2024 2 $0 4 Director 11 Jun 2024, 16:19
AMLX Amylyx Pharmaceuticals, Inc. 16 Apr 2024 2 $0 4 Chief Medical Officer 18 Apr 2024, 20:19
AMLX Amylyx Pharmaceuticals, Inc. 27 Nov 2023 2 $0 4 Chief Medical Officer 29 Nov 2023, 16:49
AMLX Amylyx Pharmaceuticals, Inc. 27 Nov 2023 0 $0 3 Chief Medical Officer 29 Nov 2023, 16:45
RYTM RHYTHM PHARMACEUTICALS, INC. 21 Jun 2023 2 $0 4 Director 23 Jun 2023, 16:30
CRNX Crinetics Pharmaceuticals, Inc. 16 Jun 2023 2 $0 4 Director 21 Jun 2023, 17:00
RARE Ultragenyx Pharmaceutical Inc. 01 Mar 2023 2 -$175,615 4 EVP and Chief Medical Officer 03 Mar 2023, 19:00
CRNX Crinetics Pharmaceuticals, Inc. 17 Jun 2022 1 $0 4 Director 21 Jun 2022, 16:44
RYTM RHYTHM PHARMACEUTICALS, INC. 08 Jun 2022 1 $0 4 Director 10 Jun 2022, 16:09
RARE Ultragenyx Pharmaceutical Inc. 01 Mar 2022 3 -$187,935 4 EVP and Chief Medical Officer 03 Mar 2022, 17:07
RARE Ultragenyx Pharmaceutical Inc. 30 Jan 2022 1 -$109,859 4 EVP and Chief Medical Officer 01 Feb 2022, 12:39
RARE Ultragenyx Pharmaceutical Inc. 14 Oct 2021 1 -$29,129 4 EVP and Chief Medical Officer 18 Oct 2021, 19:02
RARE Ultragenyx Pharmaceutical Inc. 01 Sep 2021 6 -$225,525 4 EVP and Chief Medical Officer 02 Sep 2021, 18:11
CRNX Crinetics Pharmaceuticals, Inc. 22 Jun 2021 1 $0 4 Director 23 Jun 2021, 17:00
RYTM RHYTHM PHARMACEUTICALS, INC. 09 Jun 2021 1 $0 4 Director 11 Jun 2021, 16:05
RARE Ultragenyx Pharmaceutical Inc. 06 May 2021 1 -$41,376 4 EVP and Chief Medical Officer 10 May 2021, 18:09